Envestnet Asset Management Inc Bluebird Bio, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$11.24 - $21.0 $73,071 - $136,521	-6,501 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$18.04 - $22.09 $117,278 - $143,607	6,501 New	6,501 $208,000
Q1 2021 May 04, 2021	SELL	$16.59 - $33.89 $142,823 - $291,759	-8,609 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$27.5 - $37.92 $400,152 - $551,773	-14,551 Reduced 62.83%	8,609 $373,000
Q3 2020 Oct 09, 2020	BUY	$34.44 - $43.75 $148,092 - $188,125	4,300 Added 22.8%	23,160 $1.25 Million
Q2 2020 Jul 08, 2020	BUY	$27.12 - $45.97 $176,415 - $299,034	6,505 Added 52.65%	18,860 $1.15 Million
Q1 2020 Apr 23, 2020	BUY	$26.16 - $63.5 $110,970 - $269,367	4,242 Added 52.29%	12,355 $568,000
Q4 2019 Feb 11, 2020	SELL	$46.96 - $61.67 $152,056 - $199,687	-3,238 Reduced 28.53%	8,113 $712,000
Q3 2019 Oct 17, 2019	BUY	$59.47 - $93.1 $63,632 - $99,617	1,070 Added 10.41%	11,351 $1.04 Million
Q2 2019 Aug 02, 2019	BUY	$75.84 - $105.21 $69,393 - $96,267	915 Added 9.77%	10,281 $1.31 Million
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $19,525 - $31,545	303 Added 3.34%	9,366 $1.47 Million
Q4 2018 Feb 13, 2019	BUY	$59.1 - $93.26 $535,623 - $845,215	9,063 New	9,063 $899,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $34,388 - $45,468	-387 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$99.64 - $127.59 $996 - $1,275	10 Added 2.65%	387 $61,000
Q1 2018 May 09, 2018	BUY	$105.8 - $150.94 $1,058 - $1,509	10 Added 2.72%	377 $64,000
Q4 2017 Feb 20, 2018	BUY	$81.25 - $130.7 $3,575 - $5,750	44 Added 13.62%	367 $65,000
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $12,471 - $19,746	216 Added 201.87%	323 $45,000
Q2 2017 Aug 14, 2017	BUY	N/A	107	107 $11,000

Others Institutions Holding BLUE

# of Institutions

142

Shares Held

63.2M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$121 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$82.1 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$36.7 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$36.6 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$30.1 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $605M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account